A study has uncovered a brain-signaling pathway that can be pharmacologically manipulated in mice to reverse an autism-related pathway.
Researchers report ketamine’s antidepressive effects require activation of opioid receptors in the brain. The study highlights the interaction between depression, pain and opioid addiction.
Researchers have identified a link between depression, antidepressant use and an increased risk of developing VTE.
A nasal spray formulation of ketamine shows promise in the rapid treatment of symptoms of major depression and suicidal thoughts, according to a new study published online today in The American Journal of Psychiatry (AJP).
Imperial research suggests psilocybin can help relieve the symptoms of depression, without the ‘dulling’ of emotions linked with antidepressants.